Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Updated phase 1 results Meeting Abstract
| Authors: | O'Reilly, E. M.; Mahalingam, D.; Roach, J. M.; Miller, P. J.; Rosano, M. E.; Krause, S.; Wolf, J.; Flaherty, K.; Ryan, D. P. |
| Abstract Title: | Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Updated phase 1 results |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 234s |
| Language: | English |
| ACCESSION: | WOS:000404665406081 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.4117 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4117 -- Source: Wos |
